FIELD: medicine. SUBSTANCE: this method for preventing atrophy of testicle after rupture of tunica albuginea prescribes administering riboxine in daily dosage of 25 mg/kg immediately after injury has been received or 72 h prior to planned operation and during 30 days. Experiment involving operated testicle model has revealed the fact that disclosed method permits preserving normal amount of sex cells in ductules, fission of spermatogenic epithelium cells and normal completion of development cycle, formation of normal mature spermatozoa inclusive. At the same time, disclosed method favors preservation of endocrinic functionability of testis what can be judged by higher content of testosterone in blood plasma and greater index of relative percentage of testosterone and lutropine. Variations in all evaluated parameters of patients treated with riboxine and controls are certain with P not greater than 0.05. EFFECT: disclosed method is advantageous whenever there arise necessity in preserving male reproductive function in all cases intactness of tunica albuginea is disturbed. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR STIMULATING SPERMATOGENIC AND ANDROGEN-PRODUCING FUNCTIONS OF MALE GENITAL GLANDS | 1991 |
|
RU2040258C1 |
METHOD FOR SAVING SPERMATOGENESIS AFTER SURGICAL INTERVENTIONS ON TESTICLES | 1994 |
|
RU2099053C1 |
METHOD OF CREATING PROTECTION OF SEMINIFEROUS EPITHELIUM FOR PRESERVATION OF NORMAL SPERMATOGENESIS IN SPARING ORGAN-SAVING OPERATIONS IN CASE OF TRAUMATIC TESTICLEINJURY | 2009 |
|
RU2394582C1 |
METHOD OF TREATMENT THE SECRETORY STERILITY IN MALES | 1994 |
|
RU2089188C1 |
METHOD OF STIMULATION OF IMPAIRED SPERMATOGENESIS AND SYNTHESIS OF TESTOSTERONE USING TRANSPLANTATION OF THE NEONATAL TESTICULAR TISSUE | 2017 |
|
RU2669027C1 |
METHOD OF VARICOCELE TREATMENT | 2013 |
|
RU2558984C2 |
METHOD FOR CORRECTION OF HYPOGONADISM IN ANIMALS DURING SIMULATION OF ACUTE INJURY OF SPINAL CORD | 2017 |
|
RU2689114C2 |
METHOD FOR STIMULATION OF SPERMATOGENESIS | 2016 |
|
RU2653779C1 |
USE OF PHARMACEUTICAL COMPOSITION OF β-CYCLODEXTRIN WITH 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE FOR INCREASING/RESTORING LIBIDO | 2019 |
|
RU2782133C2 |
USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
Authors
Dates
1994-09-15—Published
1991-08-14—Filed